Beat Ernst received his PhD degree from the ETH in Zürich, Switzerland in 1978. From 1978 to 1981, he was a postdoctoral fellow with Professor Robert E. Ireland at the California Institute of Technology, Pasadena, USA, where he achieved the total synthesis of tirandamycin. In 1981, he joined the Central Research Laboratory of Ciba-Geigy in Basel, Switzerland, where he became group leader (1984) and section head (1992). After the merger of Ciba and Sandoz to Novartis Pharma AG, he moved to the therapeutic area of transplantation where he was responsible for the Selectin project. In 1998, he was appointed Professor of Molecular Pharmacy at the University of Basel. The research interests of his interdisciplinary research group of chemists, molecular biologists and pharmacists are focused on the understanding of therapeutically relevant carbohydrate-lectin interactions and the development of carbohydrate mimetic for therapeutic applications.
Biography Updated on 4 February 2009